PFF Response to COVID-19
Our experts discuss reliable information about COVID-19 and how the PFF is responding to the needs of the pulmonary fibrosis community during these challenging times.
William T. Schmidt
President and Chief Executive Officer
Pulmonary Fibrosis Foundation
Amy Hajari Case, MD, FCCP
Division of Pulmonary, Critical Care, and Sleep Medicine
Sonye Danoff, MD, PhD
Co-Director, Interstitial Lung Disease Program
Johns Hopkins School of Medicine
Robert Hallowell, MD
Pulmonary Clinic Director
Beth Israel Deaconess Medical Center
Please note that the information contained in this webinar is accurate based on data available on April 1, 2020, the date of the live presentation. New data and information may have since become available about COVID-19 and vaccines authorized for use to prevent the spread of the disease.
SPONSORED WITH THE GENEROUS SUPPORT OF
Please note that speaker titles and affiliations may have changed since the live broadcast and appear as they were at the time of recording.